Overview

A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers.

Status:
Completed
Trial end date:
2019-08-09
Target enrollment:
Participant gender:
Summary
This study will evaluate the bioavailability, palatability, safety and tolerability of entrectinib in healthy volunteers. Part 1 of the study will explore the performance of entrectinib multi-particle formulation. Part 2 will evaluate the effect of drug substance particle size on entrectinib bioavailability.
Phase:
Phase 1
Details
Lead Sponsor:
Genentech, Inc.
Treatments:
Entrectinib